• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物正交化学和光照控制的可编程尺寸变化纳米医学用于协同光动力和缺氧激活治疗。

Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy.

机构信息

School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, PR China; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, PR China.

School of Medicine, South China University of Technology, Guangzhou, 510006, PR China.

出版信息

Biomaterials. 2022 May;284:121480. doi: 10.1016/j.biomaterials.2022.121480. Epub 2022 Apr 1.

DOI:10.1016/j.biomaterials.2022.121480
PMID:35390710
Abstract

Photodynamic therapy (PDT) can aggravate the hypoxia aggravation and be further utilized for the activation of hypoxia-activated prodrug (HAP). Ideally, photosensitizers (PSs) are mainly administrated to tumor vasculatures adjacent to regions with high oxygen to effectively generate reactive oxygen species (ROS) effectively and further aggravate tumor hypoxia, while the HAP is delivered to the inner tumor as far as possible for efficient activation. However, a delivery system capable of transporting PSs and HAP to the desired region respectively for the optimum effect is urgently needed. Here, we developed a bioorthogonal click chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy. It utilized tumor acidity responsive bioorthogonal click reaction for crosslinking nanoparticles to construct a drug depot with tumor vasculatures adjacent region retention for PDT in normoxia. Under laser illumination, cleavage of the ROS-responsive thioketal (TK) crosslinker to release small sized poly(amidoamine) (PAMAM) dendrimer conjugated with HAP for enhanced tumor penetration into the hypoxic region. Therefore, this strategy could differentially deliver PSs and HAP in desired spatial distribution, eventually achieving the enhanced synergistic enhancement in the combined PDT and hypoxia-activated therapy.

摘要

光动力疗法 (PDT) 可加重缺氧恶化,并进一步用于激活缺氧激活前药 (HAP)。理想情况下,光敏剂 (PS) 主要施用于邻近高氧区域的肿瘤血管,以有效地有效产生活性氧 (ROS),进一步加重肿瘤缺氧,而 HAP 则尽可能输送到肿瘤内部,以实现高效激活。然而,迫切需要一种能够将 PS 和 HAP 分别输送到所需区域以达到最佳效果的输送系统。在这里,我们开发了一种生物正交点击化学和光照控制的程序大小可变换纳米医学,用于协同光动力和缺氧激活治疗。它利用肿瘤酸度响应生物正交点击反应交联纳米颗粒,在正常氧条件下构建具有肿瘤血管邻近区域保留的药物库,用于 PDT。在激光照射下,ROS 响应硫代缩酮 (TK) 交联剂的裂解释放与 HAP 偶联的小尺寸聚酰胺胺 (PAMAM) 树枝状聚合物,增强了药物向缺氧区域的渗透。因此,该策略可以在所需的空间分布中差异地递送 PS 和 HAP,最终实现联合 PDT 和缺氧激活治疗的协同增强。

相似文献

1
Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy.生物正交化学和光照控制的可编程尺寸变化纳米医学用于协同光动力和缺氧激活治疗。
Biomaterials. 2022 May;284:121480. doi: 10.1016/j.biomaterials.2022.121480. Epub 2022 Apr 1.
2
Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.可编程治疗性纳米级共价有机框架用于光动力治疗和缺氧激活级联化疗。
Acta Biomater. 2022 Sep 1;149:297-306. doi: 10.1016/j.actbio.2022.07.003. Epub 2022 Jul 8.
3
Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.超分子胶束作为多功能治疗试剂用于协同光动力治疗和缺氧激活化疗。
Acta Biomater. 2021 Sep 1;131:483-492. doi: 10.1016/j.actbio.2021.07.014. Epub 2021 Jul 13.
4
Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.用于化学-光动力治疗的生物激活型活性氧敏感纳米颗粒系统。
Acta Biomater. 2020 May;108:273-284. doi: 10.1016/j.actbio.2020.03.027. Epub 2020 Mar 21.
5
A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.一种杂化金属-有机骨架纳米医学介导的光动力疗法和缺氧激活型癌症化疗。
J Colloid Interface Sci. 2023 Jan;629(Pt B):379-390. doi: 10.1016/j.jcis.2022.09.061. Epub 2022 Sep 14.
6
A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrug.将光敏剂整合到缺氧激活前药中,为协同癌症治疗提供了一种有前途的策略。
Eur J Med Chem. 2022 Dec 5;243:114749. doi: 10.1016/j.ejmech.2022.114749. Epub 2022 Sep 9.
7
Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia.肿瘤酸度与生物正交化学介导的药物库构建与解构用于常氧和缺氧条件下的铁死亡
Acta Biomater. 2022 Apr 1;142:253-263. doi: 10.1016/j.actbio.2022.01.046. Epub 2022 Jan 24.
8
Cellular Hypoxia Mitigation by Dandelion-like Nanoparticles for Synergistic Photodynamic Therapy of Oral Squamous Cell Carcinoma.蒲公英样纳米粒子缓解细胞缺氧用于口腔鳞状细胞癌协同光动力治疗。
ACS Appl Mater Interfaces. 2022 Oct 5;14(39):44039-44053. doi: 10.1021/acsami.2c10021. Epub 2022 Sep 26.
9
Enhancing the Release Efficiency of a Molecular Chemotherapeutic Prodrug by Photodynamic Therapy.通过光动力疗法增强分子化疗前药的释放效率。
Angew Chem Int Ed Engl. 2022 Aug 15;61(33):e202206169. doi: 10.1002/anie.202206169. Epub 2022 Jul 5.
10
Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.基于 ROS 响应性聚合物纳米载体的化学-光动力治疗级联放大协同效应。
Theranostics. 2018 Apr 18;8(11):2939-2953. doi: 10.7150/thno.24015. eCollection 2018.

引用本文的文献

1
Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma.基于碳点的纳米颗粒:胶质母细胞瘤的一种有前景的治疗方法。
Int J Nanomedicine. 2025 May 31;20:7061-7092. doi: 10.2147/IJN.S519733. eCollection 2025.
2
High-temperature PTT/CDT coordination nanoplatform realizing exacerbated hypoxia for enhancing hypoxia-activated chemotherapy to overcome tumor drug resistance.高温 PTT/CDT 协同纳米平台实现加剧缺氧以增强缺氧激活化疗克服肿瘤耐药性。
J Nanobiotechnology. 2024 Jun 26;22(1):374. doi: 10.1186/s12951-024-02653-8.
3
Enhancing Precision in Photodynamic Therapy: Innovations in Light-Driven and Bioorthogonal Activation.
提高光动力疗法的精准度:光驱动与生物正交激活方面的创新
Pharmaceutics. 2024 Mar 31;16(4):479. doi: 10.3390/pharmaceutics16040479.
4
Carbon dots as a novel photosensitizer for photodynamic therapy of cancer and bacterial infectious diseases: recent advances.碳点作为用于癌症和细菌感染性疾病光动力治疗的新型光敏剂:最新进展
J Nanobiotechnology. 2024 Apr 26;22(1):210. doi: 10.1186/s12951-024-02479-4.
5
NIR diagnostic imaging of triple-negative breast cancer and its lymph node metastasis for high-efficiency hypoxia-activated multimodal therapy.近红外诊断成像在三阴性乳腺癌及其淋巴结转移中的应用,以实现高效缺氧激活的多模态治疗。
J Nanobiotechnology. 2023 Sep 2;21(1):312. doi: 10.1186/s12951-023-02010-1.
6
NK cell-based tumor immunotherapy.基于自然杀伤细胞的肿瘤免疫疗法。
Bioact Mater. 2023 Aug 9;31:63-86. doi: 10.1016/j.bioactmat.2023.08.001. eCollection 2024 Jan.
7
Application of tumor pH/hypoxia-responsive nanoparticles for combined photodynamic therapy and hypoxia-activated chemotherapy.肿瘤pH/缺氧响应性纳米颗粒在光动力疗法与缺氧激活化疗联合治疗中的应用
Front Bioeng Biotechnol. 2023 Jun 9;11:1197404. doi: 10.3389/fbioe.2023.1197404. eCollection 2023.
8
Sandwich-Structured Implants to Obstruct Multipath Energy Supply and Trigger Self-Enhanced Hypoxia-Initiated Chemotherapy Against Postsurgical Tumor Recurrence and Metastasis.三明治结构植入物阻碍多途径能量供应并触发自增强缺氧触发化疗,以对抗术后肿瘤复发和转移。
Adv Sci (Weinh). 2023 Aug;10(22):e2300899. doi: 10.1002/advs.202300899. Epub 2023 May 8.
9
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry.生物正交化学在主动靶向和多功能药物传递系统开发中的最新进展。
Signal Transduct Target Ther. 2022 Dec 2;7(1):386. doi: 10.1038/s41392-022-01250-1.